Lower Blood Pressure Targets Linked to Slower Brain Damage, Study Finds

A new analysis of brain scans suggests that even modest reductions in blood pressure may help protect the brain from the slow damage that precedes stroke and dementia. The findings, published in eClinicalMedicine, add weight to the argument that aggressive blood pressure control has benefits beyond the heart.

Researchers from Massachusetts General Hospital and UT Health San Antonio re-examined data from SPRINT, a major US clinical trial involving more than 9,300 adults aged 50 and older with high blood pressure and elevated cardiovascular risk. Participants were randomly assigned to a systolic blood pressure target of either below 120 mmHg or below 140 mmHg.

The original trial was stopped early in 2015 after the lower-target group showed significantly fewer heart attacks, strokes, heart failure episodes, and cardiovascular deaths. Now, a fresh look at MRI data from a subset of participants suggests the benefits extend to the brain's smallest blood vessels.

What is cerebral small vessel disease?

Cerebral small vessel disease refers to damage in the tiny blood vessels that nourish brain tissue. It is a known contributor to stroke, cognitive decline, and dementia, and it can develop silently over many years before symptoms appear.

The condition shows up on MRI scans in several ways, including white matter lesions, increased water movement in white matter, and enlarged spaces around small vessels deep in the brain. No single marker tells the whole story, so the team combined three MRI signs into one statistical score to track how they changed together over time.

What the brain scans showed

Of the 663 participants with complete initial measurements, 442 had usable follow-up scans. Their average age was about 68, and a median of 3.9 years passed between scans.

By follow-up, average systolic pressure had fallen from about 136 to 120 mmHg in the lower-target group and from about 139 to 136 mmHg in the standard group. Progression of the combined MRI score was 16.9 percent lower in the group assigned the below-120 target.

The researchers also looked at actual blood pressure reductions, regardless of assigned target. Compared with participants whose pressure rose, those whose pressure fell by up to 10 mmHg had 21.2 percent less disease progression. The difference was 26.3 percent for drops of 10 to 20 mmHg and 39.4 percent for drops of at least 20 mmHg.

“The 39.4 percent means that participants whose systolic blood pressure fell by at least 20 mmHg had 39.4 percent less accumulation of small vessel disease burden, captured with our combined MRI measure, over time compared with participants whose blood pressure rose,” said Mohamad Habes, a neuroimaging researcher at UT Health San Antonio.

What the findings do and don't prove

Habes was careful to note that the results reflect slower accumulation of damage, not reversal of existing injury. “It reflects slower accumulation of small vessel disease on MRI, not reversal of existing brain injury or disappearance of 39.4 percent of lesions,” he told ScienceAlert.

The two main findings come from different comparisons. The 16.9 percent figure stems from randomised treatment targets, which provides strong causal evidence. The 39.4 percent figure is based on observed blood pressure changes, so other factors could have contributed.

“This analysis focused on MRI changes and did not establish that these participants experienced less cognitive decline or fewer strokes,” Habes said. However, earlier research has linked greater small vessel disease burden with both outcomes.

Limitations and open questions

The combined MRI score was developed after the original trial was designed, and many participants lacked usable follow-up scans. Additional analyses produced similar results, which “reduces, but does not eliminate, this concern,” Habes said.

SPRINT also excluded people with diabetes, prior stroke, dementia, symptomatic heart failure, or advanced kidney disease, as well as nursing home residents. Whether these findings apply to those groups remains uncertain.

For Australians, the findings reinforce the importance of blood pressure control as a long-term investment in brain health. With dementia rates rising across the Indo-Pacific region, prevention strategies that target vascular risk factors are drawing increasing attention from public health officials.

The research has been published in eClinicalMedicine.

Frequently asked questions

What is a normal blood pressure target?

Standard guidelines generally recommend a systolic target below 140 mmHg, but this study suggests that a lower target of below 120 mmHg may offer additional protection against brain damage in high-risk adults.

Can lowering blood pressure reverse brain damage?

No. The study found slower accumulation of small vessel disease, not reversal of existing damage. The benefits appear to come from preventing further harm rather than repairing what is already done.

Who should consider a lower blood pressure target?

The findings apply to adults aged 50 and older with high blood pressure and increased cardiovascular risk. People with diabetes, prior stroke, dementia, or advanced kidney disease were excluded from the trial, so the results may not apply to them.